Cargando…

The role of age inequalities in cause of death in the slow pace of epidemiological transition in India

In developed countries, low disparity in lifespan contributed by the reduction in the burden of noncommunicable diseases (NCDs) is the key to advances in epidemiological transition. Contrarily, India passing through a phase of the dual burden of CDs and NCDs shows a heavy burden of NCDs responsible...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Suryakant, Perianayagam, Arokiasamy, Patel, Shivani Anil, Cunningham, Solveig Argeseanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700746/
https://www.ncbi.nlm.nih.gov/pubmed/36434028
http://dx.doi.org/10.1038/s41598-022-23599-7
Descripción
Sumario:In developed countries, low disparity in lifespan contributed by the reduction in the burden of noncommunicable diseases (NCDs) is the key to advances in epidemiological transition. Contrarily, India passing through a phase of the dual burden of CDs and NCDs shows a heavy burden of NCDs responsible for the high disparity in lifespan. The Gini coefficient was decomposed for examining the contribution of 22 causes of death and their repercussions for inequality in age at death for 30 years between 1990–1994 and 2015–2019, using Global Burden of Disease data. The outcomes of the study reveal that India’s epidemiological transition has been just modest on account of high inequality in mortality by NCDs emplaced in the middle through old age despite a consistent mortality decline at infant through old age for communicable diseases (CDs). The structural changes in causes of death structure is shaped by CDs rather than NCDs, but overall bolstered by the adult mortality decline, especially in women. However, the process is restrained by the small contribution of the middle age group and a benign contribution of old mortality decline owing to the low threshold age. India needs to target health interventions in seeking significant mortality decline in the middle age group of 50–69 years that is warranted for epidemiological transition apace as evident in the developed nations.